Viemed Healthcare, Inc.
VMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $273 | $287 | $313 |
| - Cash | $11 | $20 | $10 | $18 |
| + Debt | $22 | $7 | $7 | $7 |
| Enterprise Value | – | $260 | $284 | $302 |
| Revenue | $72 | $63 | $59 | $61 |
| % Growth | 14% | 6.6% | -2.6% | – |
| Gross Profit | $41 | $36 | $33 | $36 |
| % Margin | 57.5% | 57.7% | 56.3% | 59.5% |
| EBITDA | $13 | $12 | $10 | $13 |
| % Margin | 18.3% | 19% | 17.7% | 21.1% |
| Net Income | $4 | $3 | $3 | $4 |
| % Margin | 4.9% | 5% | 4.4% | 7.1% |
| EPS Diluted | 0.09 | 0.077 | 0.06 | 0.1 |
| % Growth | 17.2% | 28% | -40% | – |
| Operating Cash Flow | $18 | $12 | $3 | $15 |
| Capital Expenditures | -$8 | -$8 | -$15 | -$12 |
| Free Cash Flow | $11 | $4 | -$13 | $3 |